Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis
Abstract
Background Recognizing the cause of optic neuritis (ON) affects treatment decisions and visual outcomes. Objective We aimed to define radiological features of first-episode demyelinating ON. Methods We performed blinded radiological assessment of 50 patients presenting with first-episode myelin oligodendrocyte glycoprotein (MOG) antibody-associated ON (MOG-ON; n=19), aquaporin-4 (AQP4) antibody-associated ON (AQP4-ON; n=11), multiple sclerosis (MS)-associated ON (MS-ON; n=13), and unclassified ON (n=7). Results Bilateral involvement was more common in MOG-ON and AQP4-ON than MS-ON (84% vs. 82% vs. 23%), optic nerve head swelling was more common in MOG-ON (53% vs. 9% vs. 0%), chiasmal involvement was more common in AQP4-ON (5% vs. 64% vs. 15%), and bilateral optic tract involvement was more common in AQP4-ON (0% vs. 45% vs. 0%). Retrobulbar involvement was more common in MOG-ON, whereas intracranial involvement was more common in AQP4-ON. MOG-ON and AQP4-ON had longer lesion lengths than MS-ON. The combination of two predictors, the absence of magnetic resonance imaging brain abnormalities and a higher lesion extent score, showed a good ability to discriminate between an autoantibody-associated ON (MOG or AQP4) and MS. AQP4-ON more frequently had severe and sustained visual impairment. Conclusion MOG-ON and AQP4-ON are more commonly bilateral and longitudinally extensive. MOG-ON tends to involve the anterior optic pathway, whereas AQP4-ON the posterior optic pathway.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A recently identified subgroup of AQP4-IgG seronegative NMOSD patients have antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) and may have a more favourable course.
“A recently identified subgroup of AQP4-IgG seronegative NMOSD patients have antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) 56 and may have a more favourable course.50,57”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [50]
Lesions extending over more than half the length of the optic nerve, and sometimes into the optic chiasm, are characteristic of NMOSD.
“Lesions extending over more than half the length of the optic nerve, and sometimes into the optic chiasm are characteristic of NMOSD.49,50”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [50]
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011 · see citing works
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802 · see citing works
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
Sato, D. K., Callegaro, D., Lana-Peixoto, M. A., Waters, P. J., Jorge, F. M. D. H., Takahashi, T., Nakashima, I., Apostolos-Pereira, S. L., Talim, N., Simm, R. F., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000101 · Cited by 850 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Diagnosis of multiple sclerosis: progress and challenges
Brownlee, W. J., Hardy, T. A., Fazekas, F., & Miller, D. H. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30959-x · Cited by 701 · see citing works
Self-citationAtypical inflammatory demyelinating syndromes of the CNS
Hardy, T. A., Reddel, S. W., Barnett, M. H., Palace, J., Lucchinetti, C. F., & Weinshenker, B. G. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30043-6 · Cited by 161 · see citing works
Self-citation
- Authors
- Ramanathan, S., Prelog, K., Barnes, E. H., Tantsis, E. M., Reddel, S. W., Henderson, A. P., Vucic, S., Gorman, M. P., Benson, L. A., Alper, G., Riney, C. J., Barnett, M., Parratt, J. D., Hardy, T. A., Leventer, R. J., Merheb, V., Nosadini, M., Fung, V. S., Brilot, F., & Dale, R. C.
- Affiliations
- The University of Sydney (AU)
- Children's Hospital at Westmead (AU)
- Boston Children's Hospital (US)
- Children’s Hospital of Pittsburgh, Department of Pediatrics, University of Pittsburgh, School of Medicine, Pittsburgh, United States of America
- The University of Queensland (AU)
- Royal Children's Hospital (AU)
- Corresponding author
- Dale, Russell C
- ORCID
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2015-07-10
- Volume
- 22
- Issue
- 4
- Pages
- 470-482
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W1878669653
- Cited by
- 384
- References
- 3
- Citations by year
- 2026: 23 · 2025: 26 · 2024: 41 · 2023: 37 · 2022: 49 · 2021: 48 · 2020: 46 · 2019: 40 · 2018: 41 · 2017: 20 · 2016: 11 · 2015: 2
- FWCI
- 19.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Multiple Sclerosis Journal (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Keywords
- optic neuritis, myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, multiple sclerosis, demyelinating optic neuritis, radiological features, lesion extent, optic nerve head swelling, visual impairment, differential diagnosis
- MeSH terms
- Adolescent, Adult, Autoantibodies, Child, Child, Preschool, Diagnosis, Differential, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Multiple Sclerosis, Optic Neuritis, Predictive Value of Tests, Retrospective Studies, Biomarkers, Age of Onset, Aquaporin 4, Young Adult, Myelin-Oligodendrocyte Glycoprotein, Optic Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review